Zynex Inc.

2.14
-0.04 (-2.06%)
At close: Apr 14, 2025, 12:51 PM
-2.06%
Bid 2.08
Market Cap 64.69M
Revenue (ttm) 192.35M
Net Income (ttm) 2.99M
EPS (ttm) 0.09
PE Ratio (ttm) 23.78
Forward PE 16.93
Analyst Hold
Ask 2.22
Volume 78,381
Avg. Volume (20D) 248,788
Open 2.23
Previous Close 2.19
Day's Range 2.13 - 2.23
52-Week Range 1.93 - 12.34
Beta 1.10

About ZYXI

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by fiel...

Sector Healthcare
IPO Date Feb 25, 2004
Employees 1,000
Stock Exchange NASDAQ
Ticker Symbol ZYXI
Full Company Profile

Analyst Forecast

According to 3 analyst ratings, the average rating for ZYXI stock is "Hold." The 12-month stock price forecast is $10.25, which is an increase of 378.97% from the latest price.

Stock Forecasts

Next Earnings Release

Zynex Inc. is scheduled to release its earnings on Apr 29, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-51.29%
Zynex shares are trading lower after HC Wainwright... Unlock content with Pro Subscription
1 month ago
-2.37%
Zynex shares are trading lower following worse-than-expected Q4 financial results.